Fyodor Biotechnologies

From Disrupting Africa
Jump to: navigation, search
Fyodor Biotechnologies
Founded2008; 12 years ago (2008)
FounderDr Eddy Agbo
Number of locations
Nigeria, USA (Maryland)

Editor: Tamia Adolph

Fyodor Biotechnologies is a biotech startup established by Dr Eddy Agbo that delivers innovative technological solutions for health problems globally. Fyodor’s flagship product is the Urine Malaria Test (UMT), which is the first and only non-blood test that is able to diagnose whether a fever is malaria-related or not, in 25 minutes or less.[1]

This innovation has taken malaria testing to an inexpensive, consumer-based model which has sold half a million tests in Nigeria in 2019.[2]


Fyodor (which means “Divine Gift”) was founded in 2008 by Nigerian entrepreneur Dr Eddy Agbo.[3] As a postdoctoral fellow in infectious disease at John Hopkins University, Dr Eddy Agbo was inspired to create a testing service that is commercially viable and affordable. [4] The UMT underwent clinical trials led by The University of Lagos, John Hopkins University, Duke University, and Nigerian health groups and was eventually verified as an accurate blood test.[5] After the clinical trials in 2013, the UMT was commercialised in 2019 in Nigeria.[6]

The UMT was conceptualised in order to create easy access to malaria testing for consumers, similar to a pregnancy test or blood sugar test.[7] Fyodor’s UMT is a urine test where patients simply urinate on a stick, and wait 25 minutes or less in order to identify whether they have malaria or not. The test does not require health care professionals or expensive medical equipment. It is an easy-to-use, at-home urine test. The UMT costs $2 per product, as an introductory price.[8]

Dr Agbo moved to Maryland, USA in order to work as a senior researcher at John Hopkins University. It was during his time in the USA that he conceptualised Fyodor Biotechnologies.[9]


In 2011, Fyodor Biotechnologies was granted a Small Business Innovation Research (SBIR) Phase 1 grant worth $150,000 by the National Science Foundation.[10]In 2012, the company received a SBIR Phase 2 grant worth $476,000 by the National Science Foundation.[11]

Awards and Recognition

The UMT won the inaugural 2015 Health Innovation Challenge Awards in Nigeria.[12]

In 2016, the UMT was chosen for the Special Prize for Social Impact at the Innovation Prize for Africa from the African Innovation Foundation. [13]Fyodor Biotechnologies was awarded the 10th edition Universal Biotech Innovation prize in 2018 for the UMT product under the category “Medtech”.[14]Fyodor Biotechnologies participated in the Africa 2018 Investment Forum in Sharm el Sheik, Egypt.[15]